Introduction
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting 5-10% women of reproductive age. 1 The most widely accepted diagnostic criteria is given by the National Institutes of Health (NIH) in 1990 defining it as hyperandrogenism and chronic anovulation in cases where secondary causes (such as adult onset congenital adrenal hyperplasia, hyperprolactinema and androgen secreting neoplasm) have been excluded. 2 Though the majority of women with PCOS have basal hyperinsulinemia, studies that carefully assessed â cell function have discovered important defect in insulin secretion. [3] [4] [5] In these women, incremental insulin secretory responses to meal are markedly reduced. 3 Impairment of â cell function to respond to oscillation in plasma glucose and insulin secretory dysfunction in PCOS contributed significantly in the development of glucose intolerance. 5 Insulin resistance and pancreatic β cell dysfunction are both implicated in the pathophysiology of glucose intolerance. 6 Obesity, particularly upper body obesity, is common among women with PCOS and it is well known that obesity increases the risk of glucose intolerance. 7 Impaired glucose intolerance (IGT) and type 2 diabetes mellitus (T2DM) in women with PCOS varies between 31-35% and 7.5-10% respectively. 8, 9 Although IGT and diabetes were detected in non-obese and/or young PCOS women, the prevalence of both significantly increase with body mass index (BMI). 8 Increased age substantially increases risk of IGT or diabetes. 9 The conversion from IGT to T2DM is accelerated, perhaps as much as 5 to 10 fold in PCOS. 8 The increased prevalence of abnormal glucose tolerance is not a universal feature. Ciampelli et al. reported that IGT is present only in obese hyperinsulinemic PCOS women with prevalence of 15.5% and none is affected by T2DM. 10 Apart from the issue of BMI, the disagreement regarding the extent and nature of abnormal glucose tolerance may be due to the presence of racial heterogenecity, known to be present regarding glucose metabolism. Thus, it is important to investigate this issue in different populations. Since environmental factors and lifestyles play a key role in the development of glucose intolerance, it becomes additionally important to conduct such study in various ethnic groups. The present study has been undertaken in the above context to characterize glucose intolerance in a group of Bangladeshi PCOS women. PCOS was diagnosed by oligomenorrhea (menstrual cycle interval >35 days but <6 months duration) or amenorrhea (if no menstruation for 6 months or more), altered FSH to LH ratio (2:1) and one or more of the following criteria: subfertility, obesity, hirsutism, cystic acne, ultrasound evidence of bilateral enlarged ovaries with multiple (10 or more) small subcortical follicles (2-10 mm in diameter). Patients with PCOS along with known diabetes and other endrocrinopathy (e.g. hyperadrenalism, hypothyroidism) were excluded from the study.
Methods

Study subjects
Methodology
A detailed history (personal, family, medical) was taken and findings were noted in predesigned case record form. The body weight (kg) was measured on light clothes and height (cm) by using appropriate scales on bare foot (Detect-Medic, Detect Scales INC,USA). BMI was calculated using standard formula. Details anthropometry was measured by standard method.
Oral glucose tolerance test (OGTT) was performed in all subjects following the world health organization (WHO) criteria (1999). 11 The selected subjects were requested to fast overnight (8-12 hours). On the following morning, fasting blood samples (2 ml) was collected in a tube. After two hours of glucose load (75 gm), another 2 ml blood was drawn in another tube.
The results were expressed as mean±standard deviation (SD) and median (range). Students unpaired t test, MannWhitney U test and X 2 were used for data analysis. Pvalue of <0.05 was considered as significant. All statistical analyses were performed with the Statistical Package for Social Science (SPSS) software for Windows version 11.5 (SPSS Inc, Chicago, IL, USA).
Results
Clinical Characteristics of the study subjects
Total patients were 103 and their age ranged from 15 to 36 years. Base-line and anthropometric characteristics and clinical manifestations are presented in Table I . 
Frequency distribution of PCOS subjects according to glucose tolerance
Among the study subjects, 30 (29.1%) had IGT, 5(4.9%) had T2DM and 68 (66%) had normal glucose tolerance (NGT).
Clinical characteristics of different groups of PCOS
Detailed anthropometry and other clinical characteristics of different groups of PCOS are presented in Table II .
Results are expressed as mean±SD and median (range) as appropriate. It was seen that patients with T2DM were older than patients with NGT and IGT and the difference was statistically significant (Table II) . BMI of T2DM patients was also significantly higher than NGT (p=0.005). Triceps of IGT was significantly higher than NGT (p=0.009). 8 Ehrmann et al. also studied on prevalence of IGT and DM in PCOS (mixed ethnic) women in Chicago and reported that 35% of PCOS had IGT and 10% had T2DM. 9 Another study showed the prevalence of IGT in PCOS women is 30%-50% and that of T2DM is 5%-10%. 15 In addition the conversion from IGT to T2DM was increased. 15 Our data on IGT is almost comparable with their findings. However, there was a difference regarding the prevalence of T2DM, which was higher in their population. This may be due to presence of higher BMI of PCOS subjects in their studies. In Ehrmann's study BMI of non-insulin dependent DM (NIDDM) PCOS was 41.0±2. It has been suggested that family history of diabetes worsens insulin secretion and glucose tolerance in PCOS women. 13 We observed that 80% of DM and 63.3% of IGT with PCOS had family history of DM, whereas 39% of NGT with PCOS had family history of DM. So, PCOS women with family history of DM are at greater risk for developing IGT and subsequently T2DM. Thus, there is a strong genetic component in the etiopathogenesis of PCOS and it needs to be explored.
Fifty percent PCOS women are usually obese. 14 In our study, we also observed about 50% of PCOS had BMI>25 Kg/m. 2 We also observed that diabetic PCOS women were significantly more obese than those with NGT (p=0.005). Obesity acts as an additional factor for developing DM in PCOS. 8, 9 In our study we found that there was no difference of BMI between IGT and NGT. Therefore, we can say that PCOS may be an independent factor for developing of IGT and BMI seems to be an additional factor for worsening glucose intolerance in PCOS.
Conclusions
PCOS women have significantly increased prevalence of IGT and T2DM. Obesity and increasing age substantially increase risk of glucose intolerance, but IGT and T2DM can develop independent to obesity in PCOS women. It may be recommended all women with PCOS have done OGTT at diagnosis. Regular follow-up can be useful in both long-term clinical management and encouraging patient lifestyle modification.
